search button

Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression

  • Authors:
    • Mohamed Fawzy
    • Mohamed El‑Beltagy
    • Maged El Shafei
    • Mohamed Saad Zaghloul
    • Naglaa Al Kinaai
    • Amal Refaat
    • Sarah Azmy

  • View Affiliations

  • Published online on: December 12, 2014     https://doi.org/10.3892/ol.2014.2795
  • Pages: 907-911
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Malignant spinal cord compression (MSCC) is a common complication of cancer. Paraspinal neuroblastoma (NB) in the thoracic, abdominal and pelvic regions may extend into the neural foramina causing compression of nerve roots and even the spinal cord. The prompt initiation of specific treatment can improve the neurological outcome. The aim of the present study was to review the clinical features, the management received and the factors that may affect the outcome of patients with MSCC caused by paraspinal NB. During a period between July 2007 and December 2012, a total of 576 NB patients were treated at the Children's Cancer Hospital (Cairo, Egypt). Intraspinal disease extension was present in 51 patients (9%). The children with intraspinal disease extension were reviewed for disease pattern, neurological manifestations and treatment outcome. Children with intraspinal disease extension had an equal male to female ratio (1:1), and approximately two‑thirds of patients (34/51) had a clinically manifested cord compression. The duration of neurological manifestations was >4 weeks in 58.8% (20/34) of symptomatic patients and ≤4 weeks in 41.2% (14/34). Subsequent to starting treatment, neurological manifestations showed a complete recovery in 16 patients (47.1%), partial in 11 (32.4%), and stationary course was found in 7 (20.6%). Manifestations of ≤4 weeks in duration carried an improved outcome compared with longer time compression, with a complete recovery in 78.6%, versus 25% for patients with a longer symptom duration (P=0.008). The upfront treatment, patient age and site of the primary tumor did not significantly affect the neurological outcome. Spinal cord compression in NB can be effectively managed with upfront chemotherapy. Initial surgical decompression should be reserved for benign variants only, including ganglioneuroma. Neurological manifestations of <4 weeks duration upon presentation are usually reversible.
View References

Related Articles

Journal Cover

February-2015
Volume 9 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Fawzy M, El‑Beltagy M, El Shafei M, Zaghloul MS, Al Kinaai N, Refaat A and Azmy S: Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression. Oncol Lett 9: 907-911, 2015
APA
Fawzy, M., El‑Beltagy, M., El Shafei, M., Zaghloul, M.S., Al Kinaai, N., Refaat, A., & Azmy, S. (2015). Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression. Oncology Letters, 9, 907-911. https://doi.org/10.3892/ol.2014.2795
MLA
Fawzy, M., El‑Beltagy, M., El Shafei, M., Zaghloul, M. S., Al Kinaai, N., Refaat, A., Azmy, S."Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression". Oncology Letters 9.2 (2015): 907-911.
Chicago
Fawzy, M., El‑Beltagy, M., El Shafei, M., Zaghloul, M. S., Al Kinaai, N., Refaat, A., Azmy, S."Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression". Oncology Letters 9, no. 2 (2015): 907-911. https://doi.org/10.3892/ol.2014.2795